NeOnc Technologies Holdings, Inc. (NTHI)
3.19
-0.01
(-0.31%)
USD |
NASDAQ |
Nov 06, 10:45
NeOnc Technologies Holdings Shareholders Equity (Quarterly) : -18.53M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -18.53M |
| March 31, 2026 | -13.23M |
| December 31, 2025 | -17.51M |
| September 30, 2025 | -11.81M |
| June 30, 2025 | -11.82M |
| March 31, 2025 | -9.624M |
| Date | Value |
|---|---|
| December 31, 2024 | -5.505M |
| September 30, 2024 | -5.267M |
| March 31, 2024 | |
| December 31, 2023 | -13.99M |
| September 30, 2023 | -10.34M |
| December 31, 2022 | -1.575M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | 1.044M |
| CNBX Pharmaceuticals, Inc. | -2.660M |
| Arvinas, Inc. | 513.80M |
| Fulcrum Therapeutics, Inc. | 310.70M |
| Definium Therapeutics, Inc. | 918.68M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.232M |
| Total Liabilities (Quarterly) | 23.76M |
| Debt to Equity Ratio | -0.0177 |
| Current Ratio | 0.1438 |
| Net Debt Paydown Yield | -0.06% |